Literature DB >> 208678

Experimental infection of Callithrix Jacchus marmosets with Herpesvirus ateles, Herpesvirus saimiri, and Epstein Barr virus.

D V Ablashi, G Pearson, H Rabin, G Armstrong, J Easton, M Valerio, J Cicmanec.   

Abstract

We inoculated common marmosets (Callithrix Jacchus) with Herpesvirus ateles (HVA), Herpesvirus saimiri (HVS), and Epstein-Barr virus (EBV). HVA-induced tumors contained several cell types, including giant cells reminiscent of the Sternberg-Reed cells observed in human Hodgkin's disease. HVS and EBV did not induce tumors, although HVS was present in lymphocytes and elicited a strong antibody response. EBV elicited only a variable antibody response. We feel that more common marmosets should be used to determine if the pathologic and immunologic lesions caused by HVA would be a suitable animal model for Hodgkin's disease and/or other malignant lymphomas of man. Inconsistency in the induction of tumors by EBV and HVS in common marmosets suggets that this species may be a different type of model for human cancer research than the cottontop marmoset, which is the most susceptible animal host for EBV and HVS oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208678

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  3 in total

1.  Ultrastructural studies on the replication of herpes virus ateles-73 in owl monkey kidney cells.

Authors:  J Luetzeler; U I Heine; E Wendel; U Prasad; D V Ablashi
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization.

Authors:  R C Desrosiers; D P Silva; L M Waldron; N L Letvin
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Mitogenic effect of 12-0 tetradecanoyl phorbol 13-acetate on non-human primate mononuclear cells and in vitro interaction with Epstein-Barr virus transformation.

Authors:  S K Sundar; D V Ablashi; Z H Bengali; P H Levine; M Nonoyama
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.